Bioeconomy Information Sharing and Analysis Center
https://www.isac.bio/Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 30, 2026 | Guest article: Executive impersonation threats are everywhere in agriculture. This is how to respond | Andrew Rose is a BioAg advisor to The Bioeconomy Information Sharing and Analysis Center (BIO-ISAC), a nonprofit building cybersecurity resilience within the life sciences, biotech, and broader bioeconomy. The views expressed in this articl... |
| Feb 7, 2025 | New Reports Call for Genomic Data Integrity and Genetic Data Categorization to Safeguard the Future of the Bioeconomy | BIO-ISAC (isac.bio) Join us in February: cyberbiosecuritysummit.org New reports from Bioeconomy ISAC (isac.bio) focus on genomic data integrity and data categorization, highlighting gaps in current approaches to data security. Our genetic i... |
| Jan 13, 2025 | Bioeconomy Information Sharing and Analysis Center Announces 2025 Cyberbiosecurity Summit Speakers | For more information, visit cyberbiosecuritysummit.org BIO-ISAC (isac.bio) Event details for the Cyberbiosecurity Summit can be found at cyberbiosecuritysummit.org. WASHINGTON, DC, UNITED STATES, January 13, 2025 /EINPresswire.com/ -- Today... |
| Nov 23, 2021 | A fledgling transpacific biotech grabs a launch round to dive into oncology and autoimmune research | Precision-med biotech Allorion Therapeutics is expanding — and now has tens of millions of dollars more to work with. The Natick, MA-based company announced in a statement this morning that it closed a Series A round, bri... |
| Nov 23, 2021 | UPDATED: The latest threat to the manufacturing industry: suspicious malware | Supply chain issues and an inspection backlog have hindered manufacturing’s seemingly endless boom, following an influx of money. But a new threat looms over the industry: a strain of Windows malware. BIO-ISAC, an inte... |
| Nov 23, 2021 | Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron | Vaccibody who? A little over a year after securing a $700 million-plus deal with Roche for its neoantigen cancer vaccine, the Norwegian biotech has attracted yet another Big Pharma partner with deep pockets — and with it,... |
| Nov 23, 2021 | Dragonfly gets Merck on second TriNKET candidate since 2018 collab; Chinese eye gene therapy developer nabs $60M | Dragonfly Therapeutics is doing better and better in getting Big Pharma on its TriNKET platform. First Celgene, then BMS, and now Merck — again. After Merck licensed its first candidate from the platform back in Novemb... |
| Nov 23, 2021 | Covid-19 roundup: WHO looks to boost production of antibody tests in lower-income countries; US government fights to uphold workplace vaccine mandate | While Europe is in the midst of a massive fourth Covid-19 surge, the UK has largely avoided the high levels of hospitalizations and deaths seen on the rest of the continent. And AstraZeneca CEO Pascal Soriot suggested Tuesday the reason for... |
| Nov 23, 2021 | At busy Visp site, Lonza will up microbial services by 50% | In an effort to up its development of microbial-derived proteins, Swiss CDMO Lonza will invest in its manufacturing capacities in its home country. The extension will be good to go by the end of this year, the company... |
Reviews 0
FAQ about Bioeconomy Information Sharing and Analysis Center
What has the press written about Bioeconomy Information Sharing and Analysis Center?
Parsers VC has collected 10 articles mentioning Bioeconomy Information Sharing and Analysis Center, among them “Guest article: Executive impersonation threats are everywhere in agriculture. This is how to respond” (Oct 30, 2026) and “New Reports Call for Genomic Data Integrity and Genetic Data Categorization to Safeguard the Future of the Bioeconomy” (Feb 7, 2025).
Is Bioeconomy Information Sharing and Analysis Center still active?
Yes, Bioeconomy Information Sharing and Analysis Center is active; its latest activity on Parsers VC dates from Nov 5, 2026.